Case series: MRD negativity assessment using (11)C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma

Complete response (CR) is an important favorable factor for survival in multiple myeloma (MM). However, CR patients continue to relapse, especially in the presence of minimal residual disease (MRD). Bone marrow (BM) MRD is predictive of progression-free survival (PFS) in MM. However, myeloma outside...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngai, Cheong, Kumar, Shaji, Chi-lai Ho, Garrett, Chen, Sirong, Chim, Chor-sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Advances in Multiple Myeloma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488511/
https://www.ncbi.nlm.nih.gov/pubmed/34616538
http://dx.doi.org/10.1177/20406207211030369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488511/
https://www.ncbi.nlm.nih.gov/pubmed/34616538
http://dx.doi.org/10.1177/20406207211030369

Ejemplares similares